Fred E. Cohen - Sep 7, 2023 Form 4 Insider Report for UroGen Pharma Ltd. (URGN)

Role
Director
Signature
/s/ Jason Smith, Attorney-in-Fact
Stock symbol
URGN
Transactions as of
Sep 7, 2023
Transactions value $
$0
Form type
4
Date filed
9/8/2023, 03:42 PM
Previous filing
Jul 28, 2023
Next filing
Feb 7, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction URGN Stock Option (right ot buy) Award $0 +10K $0.00 10K Sep 7, 2023 Ordinary Shares 10K $16.85 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the stock option will vest in equal quarterly installments over a period of one year.